Outpace Bio

Outpace Bio uses AI and cell programming to design T‑cell therapies for solid tumors, aiming to improve efficacy and safety in immune responses.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series B
Initial Investment Year
2024